TBP as a candidate gene for mental retardation in patients with subtelomeric 6q deletions

European Journal of Human Genetics

Volumn 14, Issue 10, 2006, Pages 1090-1096

  Rooms, Liesbeth ^a   Reyniers, Edwin ^a   Scheers, Stefaan ^a   van Luijk, Rob ^a   Wauters, Jan ^a   Van Aerschot, Leen ^b   Callaerts Vegh, Zsuzsanna ^b   D'Hooge, Rudi ^b   Mengus, Gabrielle ^c   Davidson, Irwin ^c   Courtens, Winnie ^a   Kooy, R Frank ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Knockout mouse; Mental retardation; Microcephaly; Subtelomeric deletion; TBP; 6q terminal deletion

Indexed keywords

TATA BINDING PROTEIN;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 6Q; CHROMOSOME DELETION; CISTERNA MAGNA; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN TISSUE; MALE; MENTAL DEFICIENCY; MICROCEPHALY; MONOZYGOTIC TWINS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN FIELD BEHAVIOR; PALATE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ROTAROD TEST; SEIZURE; TELOMERE; UPPER LIP;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ANIMALS; ANXIETY; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 6; DISEASES IN TWINS; FEMALE; HUMANS; MALE; MEMORY DISORDERS; MENTAL RETARDATION; MICE; PEDIGREE; TATA-BOX BINDING PROTEIN; TWINS, MONOZYGOTIC;

EID: 33749077523     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201674     Document Type: Article

References (22)

1. de VrAes BBA, Winter R, Schinzel A, van Ravenswaaij-Arts C: Telomeres: a diagnosis at the end of the chromosomes. J Med Genet 2003; 40: 385-398.
2. Flint J, Knight S: The use of telomere probes to investigate submicroscopic rearrangements associated with mental retardation. Curr Opin Genet Dev 2003; 13: 310-316.
3. Rooms L, Reyniers E, Kooy RF: Subtelomeric rearrangements in the mentally retarded: A comparison of detection methods. Hum Mutat 2005; 25: 513-524.
4. van Bever Y, Rooms L, Laridon A et al: Clinical report of a pure subtelomeric 1qter deletion in a boy with mental retardation and multiple anomalies adds further evidence for a specific phenotype. Am J Med Genet 2005; 135A: 91-95.
5. Heilstedt HA, Ballif BC, Howard LA et al: Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet 2003; 72: 1200-1212.
6. Stewart DR, Huang A, Faravelli F et al: Subtelomeric deletions of chromosome 9q: A novel microdeletion syndrome. Am J Med Genet A 2004; 128: 340-351.
7. Kleefstra T, Smidt M, Banning MJG et al: Disruption of the gene euchromatin histone methyl transferase1 (Eu-HMTase1) is associated with the 9q34 subtelomeric deletion syndrome. J Med Genet 2005; 42: 299-306.
8. Eash D, Waggoner D, Chung J, Stevenson D, Martin CL: Calibration of 6q subtelomere deletions to define genotype/phenotype correlations. Clin Genet 2005; 67: 396-403.
9. Stevenson DA, BrothmIn AR, Carey JC et al: 6q Subtelomeric deletion: is there a recognizable syndrome? Clin Dysmorphol 2004; 13: 103-106.
10. Rooms L, Reyniers E, Wuyts W et al: Multiplex ligation-dependent probe amplification to detect subtelomeric rearrangements in routine diagnostics. Clin Genet 2006; 69: 58-64.
11. Vandesompele J, De Preter K, Pattyn F et al: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: 34.1-34.11.
12. D'Hooge R, Lullmann-Rauch R, Beckers T et al: Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis. J Neurosci 2005; 25: 6539-6549.
13. File SE, Seth P: A review of 25 years of the social interaction test. Eur J Pharmacol 2003; 463: 35-53.
14. Kraus J, Lederer G, Keri C et al: A familial unbalanced subtelomeric translocation resulting in monosomy 6q27→qter. J Med Genet 2003; 40: e48.
15. Koide R, Kobayashi S, Shimohata T et al: A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: A new polyglutamine disease? Hum Mol Genet 1999; 8: 2047-2053.
16. Wu YR, Lin HY, Chen CM et al: Genetic testing in spinocerebellar ataxia in Taiwan: Expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease. Clin Genet 2004; 65: 209-214.
17. Stevanin G, Fujigasaki H, Lebre AS et al: Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 2003; 126: 1599-1603.
18. van Roon-Mom WM, Reid SJ, Faull RL, Snell RG: TATA-binding protein in neurodegenerative disease. Neuroscience 2005; 133: 863-872.
19. Birnbacher R, Chudoba I, Pirc-Danoewinata H et al: Micro-dissection and reverse painting reveals a microdeletion 6(q26qter) in a de novo r(6) chromosome. Ann Genet 2001; 44: 13-18.
20. Hong EJ, West AE, Greenberg ME: Transcriptional control of cognitive development. Curr Opin Neurobiol 2005; 15: 21-28.
21. Martianov I, Viville S, Davidson I: RNA polymerase II transcription in murine cells lacking the TATA binding protein. Science 2002; 298: 1036-1039.
22. Spencer CM, Alekseyenko O, Serysheva E: Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome. Genes Brain Behav 2005; 4: 420-430.